Selected article for: "ADE antibody dependent enhancement and dengue virus"

Author: Bournazos, Stylianos; Gupta, Aaron; Ravetch, Jeffrey V.
Title: The role of IgG Fc receptors in antibody-dependent enhancement
  • Cord-id: agr6emyc
  • Document date: 2020_8_11
  • ID: agr6emyc
    Snippet: Antibody-dependent enhancement (ADE) is a mechanism by which the pathogenesis of certain viral infections is enhanced in the presence of sub-neutralizing or cross-reactive non-neutralizing antiviral antibodies. In vitro modelling of ADE has attributed enhanced pathogenesis to Fcγ receptor (FcγR)-mediated viral entry, rather than canonical viral receptor-mediated entry. However, the putative FcγR-dependent mechanisms of ADE overlap with the role of these receptors in mediating antiviral protec
    Document: Antibody-dependent enhancement (ADE) is a mechanism by which the pathogenesis of certain viral infections is enhanced in the presence of sub-neutralizing or cross-reactive non-neutralizing antiviral antibodies. In vitro modelling of ADE has attributed enhanced pathogenesis to Fcγ receptor (FcγR)-mediated viral entry, rather than canonical viral receptor-mediated entry. However, the putative FcγR-dependent mechanisms of ADE overlap with the role of these receptors in mediating antiviral protection in various viral infections, necessitating a detailed understanding of how this diverse family of receptors functions in protection and pathogenesis. Here, we discuss the diversity of immune responses mediated upon FcγR engagement and review the available experimental evidence supporting the role of FcγRs in antiviral protection and pathogenesis through ADE. We explore FcγR engagement in the context of a range of different viral infections, including dengue virus and SARS-CoV, and consider ADE in the context of the ongoing SARS-CoV-2 pandemic.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute lung injury: 1, 2, 3
    • absence presence and acute viral infection: 1, 2, 3
    • absence presence and adaptive immunity: 1, 2, 3, 4
    • absence presence and ade mechanism: 1
    • absence presence and low affinity: 1, 2
    • absence presence and low neutralizing: 1
    • absence presence and lung damage: 1, 2
    • absence presence and lung immunity: 1
    • absence presence and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • absence presence and lung injury: 1, 2, 3, 4
    • absence presence and lung microenvironment: 1
    • absence presence and lung parenchyma: 1
    • absence presence and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and lysosomal fusion: 1
    • absence presence and macrophage activation: 1, 2, 3
    • absence presence and macrophage function: 1
    • absence presence and macrophage monocyte: 1, 2
    • absence presence and macrophage polarization: 1